Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trajan Group HoldingsASX:TRJ -5.26%34 EV-to-OCF is 16.63 as of Aug. 26, 2026, which is 17% below its 10-year median of 19.92. GuruFocus rates ASX:TRJ with a GF Score™ of 34/100 and a GF Value™ of A$1.12 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Trajan Group Holdings ranks worse than 68.31% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Trajan Group Holdings's Enterprise Value is A$74.4 Mil.
Trajan Group Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$4.5 Mil. Therefore, Trajan Group Holdings's EV-to-OCF for today is 16.63.
The historical rank and industry rank for Trajan Group Holdings's EV-to-OCF or its related term are showing as below:
ASX:TRJ'
s EV-to-OCF Range Over the Past 10 Years
Min: 5.54 Med: 19.92 Max: 135.87
Current: 16.29
During the past 5 years, the highest EV-to-OCF of Trajan Group Holdings was 135.87. The lowest was 5.54. And the median was 19.92.
ASX:TRJ's EV-to-OCF is ranked worse than 68.31% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.695
vs ASX:TRJ: 16.29
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Trajan Group Holdings (ASX:TRJ) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Trajan Group Holdings's PE Ratio (TTM) for today is calculated as:
Trajan Group Holdings's share price for today is A$0.18.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Trajan Group Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trajan Group Holdings EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Trajan Group Holdings's EV-to-OCF falls into.
Trajan Group Holdings's current Enterprise Value is A$74.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Trajan Group Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$4.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trajan Group Holdings (ASX:TRJ) has a EV-to-OCF of 16.63 as of Aug. 26, 2026. This is 17% below median its historical median of 19.92. Over the past decade, Trajan Group Holdings' EV-to-OCF has ranged from 5.54 to 135.87. According to the industry distribution chart, Trajan Group Holdings ranks #582 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 68.3%.
Is Trajan Group Holdings' EV-to-OCF too high?
Trajan Group Holdings' current EV-to-OCF of 16.63 is 17% below median its 10-year median of 19.92. Over the past 10 years, this metric has ranged from a low of 5.54 to a high of 135.87. The Medical Devices & Instruments industry median EV-to-OCF is 7.70. Trajan Group Holdings' value of 16.63 is 116.1% above this industry median. Based on the distribution chart, Trajan Group Holdings ranks #582 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Trajan Group Holdings has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Trajan Group Holdings ranks #582 out of 852 companies for EV-to-OCF. This places Trajan Group Holdings in the lower half of its industry. The industry median EV-to-OCF is 7.70. Trajan Group Holdings' value of 16.63 is 116.1% above this benchmark. Historically, Trajan Group Holdings' own EV-to-OCF has ranged from 5.54 to 135.87 over the past decade. While the company's 10-year median is 19.92 vs. the industry median of 7.70, Trajan Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.70, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trajan Group Holdings's current EV-to-OCF of 16.63 is 116.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trajan Group Holdings's current EV-to-OCF is 16.63, which is 17% below median its own 10-year median of 19.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Trajan Group Holdings (ASX:TRJ) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.12, compared to a current price of A$0.18 — trading 83.9% below its estimated fair value. The current EV-to-OCF is 16.63, which is 17% below median its 10-year median of 19.92 and 116.1% above the Medical Devices & Instruments industry median of 7.70. Trajan Group Holdings' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Trajan Group Holdings (ASX:TRJ), the current EV-to-OCF is 16.63 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trajan Group Holdings (ASX:TRJ) Overvalued in 2026?
Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued.
The current stock price of A$0.18 is trading 83.9% below its estimated GF Value™ of A$1.12.
GuruFocus considers Trajan Group Holdings to be Possible Value Trap.
Key valuation signals for ASX:TRJ:
EV-to-OCF: 16.63 (17% below median its 10-year median of 19.92)
GF Value™: A$1.12 vs. price of A$0.18 (83.9% below fair value)
Industry Position: 116.1% above the Medical Devices & Instruments median (#582 of 852)
No single metric tells the full story. See the ASX:TRJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
34GF Score
Get the complete analysis for ASX:TRJ
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRJ has been successfully added to your 
